Cargando…

Epalrestat increases intracellular glutathione levels in Schwann cells through transcription regulation()

Epalrestat (EPS), approved in Japan, is the only aldose reductase inhibitor that is currently available for the treatment of diabetic neuropathy. Here we report that EPS at near-plasma concentration increases the intracellular levels of glutathione (GSH), which is important for protection against ox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Keisuke, Yama, Kaori, Murao, Yu, Tatsunami, Ryosuke, Tampo, Yoshiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863807/ https://www.ncbi.nlm.nih.gov/pubmed/24363998 http://dx.doi.org/10.1016/j.redox.2013.11.003

Ejemplares similares

Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells
por: Yama, Kaori, et al.
Publicado: (2014)

Glycolaldehyde induces endoplasmic reticulum stress and apoptosis in Schwann cells
por: Sato, Keisuke, et al.
Publicado: (2015)

Long-term treatment of clarithromycin at a low concentration improves hydrogen peroxide-induced oxidant/antioxidant imbalance in human small airway epithelial cells by increasing Nrf2 mRNA expression
por: Iwayama, Kuninori, et al.
Publicado: (2017)

N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model
por: Wang, Linna, et al.
Publicado: (2023)

Epalrestat tetrahydrofuran monosolvate: crystal structure and phase transition
por: Umeda, Daiki, et al.
Publicado: (2017)

Autophagy activation is required for homocysteine-induced apoptosis in bovine aorta endothelial cells
por: Sato, Keisuke, et al.
Publicado: (2020)

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
por: Sharma, S. R., et al.
Publicado: (2008)

Efficacy, safety, and tolerability of Epalrestat compared to Methylcobalamine in patients with diabetic neuropathy
por: Maladkar, Manish, et al.
Publicado: (2009)

Amelioration of Bleomycin-induced Pulmonary Fibrosis of Rats by an Aldose Reductase Inhibitor, Epalrestat
por: Li, Xianwei, et al.
Publicado: (2015)

Formulation and Characterization of Epalrestat-Loaded Polysorbate 60 Cationic Niosomes for Ocular Delivery
por: Kattar, Axel, et al.
Publicado: (2023)

Regulation of intracellular glutathione()
por: Winterbourn, Christine C.
Publicado: (2018)

Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats
por: Yang, Bai-Bing, et al.
Publicado: (2018)

Hemoglobin is an oxygen-dependent glutathione buffer adapting the intracellular reduced glutathione levels to oxygen availability
por: Fenk, Simone, et al.
Publicado: (2022)

Coordination of Schwann cell myelination and node formation at the transcriptional level
por: Fröb, Franziska, et al.
Publicado: (2021)

Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway
por: Li, Qing-rong, et al.
Publicado: (2016)

Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy
por: Wang, Xiaotong, et al.
Publicado: (2018)

Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury
por: El Gamal, Heba, et al.
Publicado: (2017)

Correction: Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats
por: Yang, Bai-Bing, et al.
Publicado: (2019)

The transcriptional profile of keloidal Schwann cells
por: Direder, Martin, et al.
Publicado: (2022)

Corrigendum to “Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury”
por: El Gamal, Heba, et al.
Publicado: (2019)

Cognition enhancing abilities of vitamin D, epalrestat and their combination in diabetic rats with and without scopolamine induced amnesia
por: Kulkarni, Utkarsha D., et al.
Publicado: (2021)

Neuroprotective Effect of Epalrestat on Hydrogen Peroxide-Induced Neurodegeneration in SH-SY5Y Cellular Model
por: Lingappa, Sivakumar, et al.
Publicado: (2021)

Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase
por: Shi, Wei, et al.
Publicado: (2023)

Intracellular glutathione pools are heterogeneously concentrated()
por: Montero, Davide, et al.
Publicado: (2013)

Glutathione and the intracellular labile heme pool
por: O’Keeffe, Rosemary, et al.
Publicado: (2020)

Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines
por: Okuno, S, et al.
Publicado: (2003)

Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson’s disease
por: Rahman, Md. Mahbubur, et al.
Publicado: (2019)

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
por: Iyer, Sangeetha, et al.
Publicado: (2019)

Glutathione S-Transferase Regulates Mitochondrial Populations in Axons through Increased Glutathione Oxidation
por: Smith, Gaynor A., et al.
Publicado: (2019)

Prodrug Approach for Increasing Cellular Glutathione Levels
por: Cacciatore, Ivana, et al.
Publicado: (2010)

Oral administration of γ-glutamylcysteine increases intracellular glutathione levels above homeostasis in a randomised human trial pilot study()
por: Zarka, Martin Hani, et al.
Publicado: (2017)

Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels.
por: Raynaud, F. I., et al.
Publicado: (1996)

Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer
por: Verschoor, Meghan L, et al.
Publicado: (2013)

Increased transcription of Glutathione S-transferases in acaricide exposed scabies mites
por: Mounsey, Kate E, et al.
Publicado: (2010)

Transcriptional inhibition in Schwann cell development and nerve regeneration
por: Quintes, Susanne, et al.
Publicado: (2017)

Intracellular Mycobacterium leprae Utilizes Host Glucose as a Carbon Source in Schwann Cells
por: Borah, Khushboo, et al.
Publicado: (2019)

Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat
por: Hotta, N, et al.
Publicado: (2008)

The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis
por: Wang, Xiaotong, et al.
Publicado: (2018)

The Aldose Reductase Inhibitor Epalrestat Maintains Blood–Brain Barrier Integrity by Enhancing Endothelial Cell Function during Cerebral Ischemia
por: Zhang, Tongshuai, et al.
Publicado: (2023)

Alteration of intracellular cysteine and glutathione levels in alveolar macrophages and lymphocytes by diesel exhaust particle exposure.
por: Al-Humadi, Nabil H, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_0f20899cjn56cja67kna40lcbd